Comparison of Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery
Public ClinicalTrials.gov record NCT01500135. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Open Label, Parallel-group, Multi-center Trial to Compare Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Hemostatic Treatment of Needle Hole Bleeding in Vascular Surgery
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Present trial is the third study that in combination with two completed studies (one being a trial in hepatic resection surgery also comparing TachoSil® and Surgicel® Original) targeted toward providing clinical safety and efficacy data to support extending the current label of TachoSil® to a general hemostasis indication across several surgical procedures and organ systems in the USA.
Study identification
- NCT ID
- NCT01500135
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 150 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 2012 (Type not available)
- Primary completion
- Jun 2015 (Actual)
- Completion
- Dec 2015 (Actual)
- Last update posted
- Feb 8, 2017
2012 – 2015
United States locations
- U.S. sites
- 37
- U.S. states
- 19
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Nycomed Investigational Site | Birmingham | Alabama | — | — |
| Not listed | Birmingham | Alabama | — | — |
| Not listed | Little Rock | Arkansas | — | — |
| Not listed | Long Beach | California | — | — |
| Nycomed Investigational Site | Los Angeles | California | — | — |
| Not listed | Los Angeles | California | — | — |
| Not listed | Loveland | Colorado | — | — |
| Not listed | Jacksonville | Florida | — | — |
| Nycomed Investigational Site | Austell | Georgia | — | — |
| Not listed | Austell | Georgia | — | — |
| Not listed | Skokie | Illinois | — | — |
| Nycomed Investigational Site | Springfield | Illinois | — | — |
| Not listed | Springfield | Illinois | — | — |
| Nycomed Investigational Site | Lexington | Kentucky | — | — |
| Not listed | Lexington | Kentucky | — | — |
| Not listed | Worcester | Massachusetts | — | — |
| Not listed | Southfield | Michigan | — | — |
| Not listed | St Louis | Missouri | — | — |
| Not listed | Hackensack | New Jersey | — | — |
| Not listed | East Setauket | New York | — | — |
| Not listed | Flushing | New York | — | — |
| Nycomed Investigational Site | New York | New York | — | — |
| Not listed | New York | New York | — | — |
| Not listed | The Bronx | New York | — | — |
| Not listed | Durham | North Carolina | — | — |
| Not listed | Raleigh | North Carolina | — | — |
| Not listed | Winston-Salem | North Carolina | — | — |
| Not listed | Toledo | Ohio | — | — |
| Not listed | Portland | Oregon | — | — |
| Nycomed Investigational Site | Galveston | Texas | — | — |
| Not listed | Galveston | Texas | — | — |
| Nycomed Investigational Site | Houston | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Lubbock | Texas | — | — |
| Nycomed Investigational Site | Bellevue | Washington | — | — |
| Not listed | Bellevue | Washington | — | — |
| Not listed | Charleston | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01500135, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 8, 2017 · Synced Oct 18, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01500135 live on ClinicalTrials.gov.